Costs associated with adverse events from remission induction for children with Acute Lymphoblastic Leukemia (ALL)

被引：0
|
作者：
Eréndira Mejía-Aranguré
Alfonso Reyes-López
Luis Enrique Juárez-Villegas
Yosef Olaf Hernández-Olivares
Alberto Daniel Saucedo-Campos
Gabriela Hernández-Pliego
Silvia Martínez-Valverde
Leticia A. Barajas-Nava
Juan Garduño-Espinosa
机构：
[1] Odontológicas Y de La Salud,Programa de Maestría y Doctorado en Ciencias Médicas
[2] Universidad Nacional Autónoma de México,Medicina Basada en Evidencia
[3] Unidad de Investigación,Departamento de Oncología Pediátrica
[4] Hospital Infantil de México Federico Gómez,Dirección de Investigación
[5] Centro de Estudios Económicos y Sociales en Salud,undefined
[6] Hospital Infantil de México Federico Gómez,undefined
[7] Hospital Infantil de México Federico Gómez,undefined
[8] Hospital Infantil de México Federico Gómez,undefined
来源：
BMC Health Services Research | / 22卷
关键词：
Children; Cost; Adverse event; Leukemia; Chemotherapy; Toxicity; Remission;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Costs associated with adverse events from remission induction for children with Acute Lymphoblastic Leukemia (ALL)
    Mejia-Arangure, Erendira
    Reyes-Lopez, Alfonso
    Enrique Juarez-Villegas, Luis
    Olaf Hernandez-Olivares, Yosef
    Daniel Saucedo-Campos, Alberto
    Hernandez-Pliego, Gabriela
    Martinez-Valverde, Silvia
    Barajas-Nava, Leticia A.
    Garduno-Espinosa, Juan
    BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [2] RISK OF ADVERSE EVENTS IN CHILDREN COMPLETING TREATMENT FOR ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
    PUI, CH
    DODGE, RK
    LOOK, AT
    GEORGE, SL
    RIVERA, GK
    EVANS, WE
    CRIST, WM
    SIMONE, JV
    PEDIATRIC RESEARCH, 1991, 29 (04) : A148 - A148
  • [3] MALNUTRITION AND NEUTROPENIA IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA DURING INDUCTION OF REMISSION
    Siddique, R.
    Mollah, L. R.
    Yasmin, F.
    Karim, M. A.
    Jamal, C. Y.
    Islam, A.
    Begum, M.
    Ara, Z.
    Ferdouse, Z.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 61 - 62
  • [4] In vivo modeling of remission-induction therapy in acute lymphoblastic leukemia (ALL)
    Muench, V
    Hasan, M. N.
    Schirmer, M.
    Eckhoff, S. M.
    Debatin, K. -M
    Meyer, L. H.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 44 - 44
  • [5] Adverse Events during Induction Therapy in Pediatric Acute Lymphoblastic Lymphoma (ALL)
    West, Zachary
    Allen, Kristen
    Monroe, Caitlin
    Castellino, Sharon M.
    Miller, Tamara P.
    BLOOD, 2019, 134
  • [6] ASSOCIATION OF SELECTED VARIABLES DURING REMISSION INDUCTION AND CONSOLIDATION WITH REMISSION DURATION IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    MURPHY, ML
    KLENK, R
    PASSE, S
    MIKE, V
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 352 - 352
  • [7] Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia
    Hurwitz, CA
    Silverman, LB
    Schorin, MA
    Clavell, LA
    Dalton, VK
    Glick, KM
    Gelber, RD
    Sallan, SE
    CANCER, 2000, 88 (08) : 1964 - 1969
  • [8] Body composition in children in remission from acute lymphoblastic leukemia
    Murphy, AJ
    Wells, JCK
    Williams, JE
    Fewtrell, MS
    Davies, PSW
    Webb, DK
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 83 (01): : 70 - 74
  • [9] Platelet aggregation in children with acute lymphoblastic leukemia during induction of remission therapy
    Jaime-Pérez, JC
    Cantu-Rodríguez, OG
    Herrera-Garza, JL
    Gómez-Almaguer, D
    ARCHIVES OF MEDICAL RESEARCH, 2004, 35 (02) : 141 - 144
  • [10] INFLUENCE OF REMISSION INDUCTION THERAPY ON FURTHER OUTCOME OF ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN
    RITTER, J
    OEHME, J
    MIEHE, G
    MEDIZINISCHE KLINIK, 1978, 73 (01) : 23 - 27
12345